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Abstract. 
 
E-cadherin is a transmembrane glycoprotein 
that mediates calcium-dependent, homotypic cell–cell 
adhesion and plays a role in maintaining the normal 
phenotype of epithelial cells. Decreased expression of
E-cadherin has been correlated with increased inva-
siveness of breast cancer. In other systems, inappropri-
ate expression of a nonepithelial cadherin, such as
N-cadherin, by an epithelial cell has been shown to 
downregulate E-cadherin expression and to contribute 
to a scattered phenotype. In this study, we explored the 
possibility that expression of nonepithelial cadherins 
may be correlated with increased motility and invasion 
in breast cancer cells. We show that N-cadherin pro-
motes motility and invasion; that decreased expression 
of E-cadherin does not necessarily correlate with motil-
ity or invasion; that N-cadherin expression correlates 
both with invasion and motility, and likely plays a direct 
role in promoting motility; that forced expression of
E-cadherin in invasive, N-cadherin–positive cells does 
not reduce their motility or invasive capacity; that 
forced expression of N-cadherin in noninvasive,
E-cadherin–positive cells produces an invasive cell, 
even though these cells continue to express high levels 
of E-cadherin; that N-cadherin–dependent motility 
may be mediated by FGF receptor signaling; and that 
cadherin-11 promotes epithelial cell motility in a man-
ner similar to N-cadherin.
Key words: N-cadherin • E-cadherin • breast cancer • 
motility • ﬁbroblast growth factor receptor
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ADHERINS
 
 constitute a family of transmembrane
glycoproteins that mediate calcium-dependent ho-
motypic cell–cell adhesion and play an important
role in the maintenance of normal tissue architecture. The
cadherin intracellular domain interacts with several pro-
teins, collectively called catenins, that link cadherins to the
actin cytoskeleton (reviewed in Wheelock et al., 1996).
This linkage is required for full cadherin adhesive activity.
Either 
 
b
 
-catenin or plakoglobin binds directly to the cad-
herin and to 
 
a
 
-catenin, whereas 
 
a
 
-catenin links directly
and indirectly to actin (Aberle et al., 1994; Nagafuchi et al.,
1994; Stappert and Kemler, 1994; Knudsen et al., 1995;
Rimm et al., 1995; Nieset et al., 1997; Watabe-Uchida et al.,
1998). Their ability to simultaneously self-associate and
link to the actin cytoskeleton enables cadherins to mediate
both the cell recognition required for cell sorting and the
strong cell–cell adhesion needed to form tissues.
In addition to their structural role in the adherens junc-
tion, catenins are thought to regulate the adhesive activity
of cadherins. For example, phosphorylation of 
 
b
 
-catenin
in Src transformed cells may contribute to the nonadhe-
sive phenotype of these cells (Matsuyoshi et al., 1992;
Hamaguchi et al., 1993). In addition, p120
 
ctn
 
, originally
identified as a Src substrate and subsequently shown to
bind to the cytoplasmic domain of cadherins, has been sug-
gested to play a role in regulating the adhesive activity of
cadherins (Reynolds et al., 1994; Daniel and Reynolds,
1995; Shibamoto et al., 1995; Aono et al., 1999; Ohkubo
and Ozawa, 1999).
Numerous studies have demonstrated the importance of
the E-cadherin/catenin complex in maintaining the normal
phenotype of epithelial cells. Early studies showed that in-
hibiting E-cadherin activity with function-perturbing anti-
bodies altered the morphology of MDCK cells and con-
ferred upon them the ability to invade both collagen gels
and embryonic chicken heart tissue (Behrens et al., 1989;
Chen and Öbrink, 1991). In addition, invasive, fibroblast-
like carcinoma cells could be converted to a noninvasive
phenotype by transfection with a cDNA encoding E-cad-
herin (Frixen et al., 1991). Moreover, E-cadherin expres-
sion is downregulated or lost in epithelial tumors from var-
ious tissues, including stomach, colon, head and neck,
bladder, prostate, and breast (Schipper et al., 1991; Brin-
guier et al., 1993; Dorudi et al., 1993; Mayer et al., 1993;
Oka et al., 1993; Umbas et al., 1994).
It has been suggested that alterations in cadherin func-
tion may be a critical step in the development of breast
cancers. A survey of 18 cell lines derived from breast carci-
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nomas showed that ten lines failed to express detectable
levels of E-cadherin, and two other lines failed to express
 
a
 
-catenin (Pierceall et al., 1995). Other studies have iden-
tified breast tumor cell lines with mutations in the E-cad-
herin gene (Berx et al., 1995), or with changes in the levels
of expression or in the phosphorylation state of 
 
b
 
-catenin
or plakoglobin (Sommers et al., 1994). Surveys of breast
cancer tissue make an equally compelling case for the in-
volvement of E-cadherin in the formation or progression
of breast tumors, and clinical studies have shown that loss
of E-cadherin correlates with metastatic disease and poor
prognosis (Gamello et al., 1993; Moll et al., 1993; Oka et al.,
1993; Rasbridge et al., 1993; Berx et al., 1996; Guriec et al.,
1996).
In vitro studies support the role of E-cadherin as an in-
vasion suppressor gene. For example, forced expression of
E-cadherin in rat astrocytoma cells suppressed motility
(Chen et al., 1997). Likewise, transfection of invasive
E-cadherin–negative breast or prostate cell lines with
mouse E-cadherin resulted in cells that were less invasive
in in vitro assays (Frixen et al., 1991; Luo et al., 1999).
When treated with function blocking E-cadherin antibod-
ies, the transfected cells returned to an invasive pheno-
type, thus implicating E-cadherin as an invasion suppres-
sor (Frixen et al., 1991).
Although a number of studies with breast carcinoma cell
lines have shown that loss of E-cadherin generally results
in an invasive phenotype, important exceptions have been
reported. In one study, two E-cadherin–negative cell lines
were shown to be noninvasive (Sommers et al., 1991).
These authors suggested that in order for E-cadherin–
negative cells to be invasive, they must also express vi-
mentin.
In another study, Sommers et al. (1994) showed that
transfection of E-cadherin into the invasive breast cancer
cell lines, BT549 and HS578t, altered neither the morphol-
ogy nor the invasive behavior of these cells. These authors
speculated that the transfected E-cadherin may not be
fully functional in these cells, due to altered posttrans-
lational modification of the cadherin-associated proteins
 
b
 
-catenin, 
 
a
 
-catenin, or plakoglobin.
It has been suggested that, unlike E-cadherin, N-cad-
herin may promote motility and invasion in carcinoma
cells. For example, Hazan et al. (1997) reported that ex-
pression of N-cadherin by breast carcinoma cells corre-
lated with invasion, and suggested that invasion was po-
tentiated by N-cadherin–mediated interactions between
the breast cancer cells and stromal cells. A study con-
ducted in our laboratory suggested that N-cadherin may
play a more direct role in the process of invasion and may
actually promote invasion by inducing a scattered pheno-
type when expressed by oral squamous cell carcinoma-
derived cells (Islam et al., 1996). In this study, forced
expression of N-cadherin resulted in downregulation of
endogenous E- and P-cadherins, making it impossible to
separate the motility-promoting effects of N-cadherin from
the motility-suppressing activity of E-cadherin. In con-
trast, it has been suggested that N-cadherin promotes con-
tact inhibition in normal skeletal muscle myoblasts and, in
so doing, inhibits migration upon contact, but does not
suppress motility in subconfluent cells (Huttenlocher et
al., 1998).
Thus, the information in the literature concerning the
role cadherins may play in tumor cell invasion is inconclu-
sive and even contradictory, prompting us to revisit the
question using new reagents generated by our laboratory
to examine both previously studied and newly derived
breast cancer cell lines. The data presented in this paper
indicate: decreased expression of E-cadherin does not
necessarily correlate with invasion in breast cancer cells;
N-cadherin expression correlates both with invasion and
motility in breast cancer cells, and likely plays a direct role
in promoting motility; forced expression of E-cadherin in
invasive, N-cadherin–positive cells does not reduce their
motility or invasive capacity; forced expression of N-cad-
herin in noninvasive, E-cadherin–positive cells produces
an invasive cell, even though these cells continue to express
high levels of E-cadherin; the data suggest that N-cadherin-
mediated cell motility may be stimulated by FGF receptor
signaling; and other cadherins, such as cadherin-11, may
promote motility in epithelial cells in a manner similar to
N-cadherin.
 
Materials and Methods
 
Cells
 
Breast carcinoma cell lines were obtained from American Type Culture
Collection (ATCC) and maintained in DME with 10% FBS (SKBr3,
MDA-MB-435, MDA-MB-436, BT-549, and Hs578t) or MEM with 10%
FBS (MDA-MB-453 and BT-20). The cell lines MCF-7 and MDA-MB-
231 were obtained from Dr. Mary J.C. Hendrix (University of Iowa, Iowa
City, IA) and maintained in DME with 10% FBS. The cell lines SUM
159PT and SUM 149 were kindly provided by Dr. Steve Ethier and gener-
ated by the University of Michigan Human Breast Cell/Tissue Bank and
Data Base. They were maintained in Ham’s F-12 with 5% FBS supple-
mented with insulin (5 mg/ml) and hydrocortisone (1 mg/ml). The cell line
SUM 1315 was obtained from the same source and maintained in Ham’s
F-12 with 5% FBS supplemented with insulin (5 mg/ml) and EGF (10 ng/
ml). HT1080 cells were obtained from ATCC and maintained in DME
with 10% FBS.
 
Transfections
 
To transfect MDA-MB-435 with E-cadherin, the calcium phosphate trans-
fection kit (Stratagene) was used, according to manufacturer’s protocol.
For electroporations (BT-20 cells), 10
 
6
 
 cells were washed with PBS and re-
suspended in electroporation buffer (120 mM KCl, 0.15 mM CaCl
 
2
 
, 10 mM
K
 
2
 
HPO
 
4
 
, 10 mM KH
 
2
 
PO
 
4
 
, 25 mM Hepes, 2 mM EGTA, 5 mM MgCl
 
2
 
)
supplemented with 2 mM ATP and 5 mM glutathione. After a 5 min incu-
bation on ice, the cells were electroporated at 500 
 
m
 
F and 380 V in a Bio-
Rad gene pulser. Cells were immediately plated in a 100-mm dish in com-
plete medium. Floating cells were removed and fresh medium was added
24 h after electroporation; puromycin was added to the culture for selec-
tion of clones 48 h after electroporation.
 
Clones and Vectors
 
For transfection of N-cadherin, a restriction fragment containing nucle-
otides 442–3362 (GenBank/EMBL/DDBJ accession number S42303; a
kind gift of Dr. Avri Ben-Ze’ev, The Weizmann Institute of Science, Is-
rael) was ligated into the expression vector pLK-pac (Islam et al., 1996).
The E-cadherin construct has been described previously (Lewis et al.,
1997). The human cadherin-11 cDNA was provided by Drs. S. Takashita
and A. Kudo (Tokyo Institute of Technology, Japan; accession number
D21254; Okazaki et al., 1994).
 
Antibodies and Reagents
 
Unless otherwise stated, all reagents were from Sigma Chemical Co. Rab-
bit polyclonal antibodies (Jelly) against human E-cadherin extracellular
domain (Wheelock et al., 1987), and mouse mAbs against E-cadherin 
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(HECD1; a kind gift of Dr. Masatoshi Takeichi, Kyoto University, Kyoto,
Japan) and N-cadherin (13A9; Knudsen et al., 1995, Sacco et al., 1995),
have been described previously. The mouse mAb against 
 
b
 
-catenin (6E3)
was made as described by Johnson et al. (1993). The mouse mAbs against
cadherin-11 were kindly provided by Dr. Marion Bussemakers (Univer-
sity Hospital Nijmegen, The Netherlands). The diacylglycerol lipase inhib-
itor, RHC80267, was purchased from BIOMOL.
 
Extraction of Cells
 
Monolayers of cells were washed with PBS at room temperature and ex-
tracted on ice with 2.5 ml/75 cm
 
2
 
 flask 10 mM Tris acetate, pH 8.0, con-
taining 0.5% NP-40 (BDH Chemicals Ltd.), 1 mM EDTA, and 2 mM
PMSF. The cells were scraped, followed by vigorous pipetting for 5 min on
ice. Insoluble material was removed by centrifugation at 15,000 
 
g
 
 for 10
min at 4
 
8
 
C. Cell extracts were resolved on 7% SDS-PAGE as described
(Lewis et al., 1994), transferred electrophoretically to nitrocellulose, and
immunoblotted as described (Wheelock et al., 1987) using primary anti-
bodies followed by ECL, according to the manufacturer’s protocol (Pierce
Chemical Co.). For the purpose of loading equal amounts of protein onto
SDS-PAGE, quantification was done using the BioRad protein assay re-
agent according to the manufacturer’s protocol.
 
Immunofluorescence and Microscopy
 
Cells were grown on glass coverslips, fixed with Histochoice (Amresco),
washed three times with PBS, and blocked for 30 min with PBS supple-
mented with 10% goat serum. Coverslips were exposed to primary anti-
bodies for 1 h, washed three times with PBS, and exposed to species-spe-
cific antibodies conjugated to FITC or rhodamine for 1 h. Cells were
viewed using a Zeiss Axiophot microscope equipped with the appropriate
filters, and photographed using Kodak T-MAX 3200 film. Living cells
were viewed using a Zeiss Axiovert microscope and photographed using
Kodak T-MAX 400 film.
 
In Vitro Invasion Assays and Motility Assays
 
For motility assays, 5 
 
3 
 
10
 
5
 
 cells were plated in the top chamber of non-
coated polyethylene teraphthalate (PET) membranes (6-well insert, pore
size 8 mm; Becton Dickinson). For in vitro invasion assays, 3 
 
3 
 
10
 
4
 
 cells
were plated in the top chamber of Matrigel-coated PET membranes (24-
well insert, pore size 8 mm; Becton Dickinson). In motility and invasion
assays, 3T3 conditioned medium was used as a chemoattractant in the
lower chamber. The cells were incubated for 24 h and those that did not
migrate through the pores in the membrane were removed by scraping the
membrane with a cotton swab. Cells transversing the membrane were
stained with Diff-Quick (Dade). Cells in ten random fields of view at 100
 
3
 
were counted and expressed as the average number of cells/field of view.
Three independent experiments were done in each case. The data were
represented as the average of the three independent experiments with the
SD of the average indicated. When cells were induced with dexametha-
sone to express a transgene, the control cells were treated with the same
level of dexamethasone. To inhibit FGF receptor signaling, cells were
treated with RHC80267 (which inhibits the activity of diacylglycerol li-
pase) at a concentration of 10–40 
 
m
 
g/ml 3T3 conditioned culture medium
during the 24 h of the assay.
 
Results
 
Expression of Cadherins by Breast Cancer Cells
 
E-cadherin has been termed a tumor suppressor, mainly
because cells derived from E-cadherin–negative epithelial
tumors tend to be invasive, whereas cells derived from
E-cadherin–positive tumors tend not to be. In the case of
cells derived from breast carcinomas, the majority of
E-cadherin–negative cells are invasive (Sommers et al.,
1991, 1994; Pierceall et al., 1995). However, an increasing
number of exceptions to this rule are becoming evident.
Our laboratory has recently shown that expression of an
inappropriate cadherin by an oral squamous carcinoma
cell line influences expression of E-cadherin and the cellu-
lar phenotype (Islam et al., 1996). This observation led us
to hypothesize that the invasiveness of some breast cancer
cells may be due to an increase in the expression of an in-
appropriate cadherin, possibly N-cadherin, rather than to
a decrease in the expression of E-cadherin. To test this hy-
pothesis, we surveyed a large number of cell lines, many of
which had been characterized previously, for expression of
E- and N-cadherin. The data, which are summarized in Ta-
ble I, supported our notion that invasiveness is correlated
with N-cadherin expression, rather than lack of E-cad-
herin expression.
Fig. 1 is an immunoblot of extracts of the cell lines pre-
sented in Table I. Equal amounts of protein were loaded
in each lane. The samples were resolved by SDS-PAGE,
transferred to nitrocellulose, and immunoblotted for E-,
N-, or P-cadherin, cadherin-11, and 
 
b
 
-catenin. Fig. 2 pre-
sents phase micrographs of the living cells to compare the
 
Table I. Cadherin Expression in Breast Carcinoma Cell Lines
 
Cell line
E-cad-
herin
N-cad-
herin
P-cad-
herin
Cad-
herin-11
 
b
 
-Catenin Motility
 
MCF-7
 
1
 
*
 
‡
 
2
 
*
 
2
 
*
 
2
 
*
 
1
 
*
 
i
 
¶
 
No*
 
‡
 
BT-20
 
1
 
*
 
2
 
*
 
1
 
*
 
2
 
*
 
1
 
* No*
SUM149
 
1
 
*
 
2
 
*
 
1
 
*
 
2
 
*
 
1
 
* No*
SKBr3
 
2
 
*
 
‡
 
2
 
*
 
2
 
*
 
2
 
*
 
2
 
*
 
i
 
¶
 
No*
 
‡
 
MDA-MB-453
 
2
 
*
 
‡
 
2
 
*
 
2
 
*
 
2
 
*
 
2
 
*
 
i
 
¶
 
No
 
‡
 
SUM1315
 
2
 
*
 
2
 
*
 
1
 
*
 
6
 
*
 
1
 
* No*
MDA-MB-435
 
2
 
*
 
‡
 
1
 
*
 
2
 
*
 
2
 
*
 
1
 
*
 
¶
 
Yes
 
§
 
MDA-MB-436
 
2
 
*
 
‡
 
1
 
*
 
2
 
*
 
2
 
*
 
1
 
*
 
i
 
¶
 
Yes
 
‡
 
BT549
 
2
 
*
 
‡
 
1
 
*
 
1
 
*
 
2
 
*
 
1
 
*
 
i
 
¶
 
Yes
 
‡
 
Hs578t
 
2
 
*
 
‡
 
1
 
*
 
2
 
*
 
2
 
*
 
1
 
*
 
i
 
¶
 
Yes*
 
‡
 
SUM159PT
 
2
 
*
 
1
 
*
 
2
 
*
 
2
 
*
 
1
 
* Yes*
MDA-MB-231
 
2
 
*
 
2
 
*
 
2
 
*
 
1
 
*
 
†
 
1
 
* Yes*
 
†
 
*Current study; 
 
‡
 
Sommers et al., 1991; 
 
§
 
Frixen et al., 1991; 
 
i
 
Sommers et al., 1994;
 
¶
 
Pierceall et al., 1995; 
 
†
 
Pishvaian et al., 1999.
Figure 1. Cadherin and b-catenin expression in breast carcinoma
cell lines. Confluent monolayers of MCF-7, BT-20, SUM 149,
SKBr3, MDA-MB-453, SUM 1315, MDA-MB-435, MDA-MB-
436, BT-549, Hs578t, SUM 159PT, or MDA-MB-231 were ex-
tracted with NP-40. 20 mg total protein from each cell extract was
resolved by SDS-PAGE, transferred to nitrocellulose, and blot-
ted with antibodies against E-cadherin (HECD1), N-cadherin,
P-cadherin, cadherin-11, or b-catenin. 
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these fibroblastic, N-cadherin–negative cell lines had low
motility and invasion rates (Table I and Fig. 3). The
N-cadherin–expressing cell lines all displayed a fibroblas-
tic phenotype, as typified by MDA-MB-435, MDA-MB-
436, and SUM159 (Fig. 2). Cell lines that did not express
any cadherin, as typified by SKBr3, displayed a fibroblas-
tic phenotype much like the N-cadherin–positive cells,
however, they were less adhesive to the substratum than
were cadherin-expressing cells. In addition, they tended to
float in the medium upon reaching confluency and when
undergoing mitosis.
 
A Role for N-Cadherin in Cell Motility
 
In this study, we hypothesized that the invasive behavior
morphologies of breast cancer cells expressing the various
members of the cadherin family. MCF-7 cells expressed
E-cadherin, had low invasion rates, and presented an epi-
thelial-like morphology. BT-20 cells expressed both E-
and P-cadherin, had low invasion rates, and presented an
epithelial-like morphology. In contrast, E-cadherin–nega-
tive cell lines did not present an epithelial morphology, but
rather appeared as fibroblast-like cells with less obvious
cell–cell interactions. Even the SUM149 cell line that ex-
pressed a small amount of E-cadherin, along with substan-
tial amounts of P-cadherin, did not have the epithelial ap-
pearance typified by the MCF-7 and BT-20 cell lines.
SUM1315 cells, which expressed P-cadherin, along with a
small amount of cadherin-11, also had a fibroblastic ap-
pearance with minimal cell–cell interactions. However,
Figure 2. Morphological
analysis of breast cancer cell
lines. Living monolayers of
MCF-7 (A), BT-20 (B), SUM
149 (C), SKBr3 (D), SUM
1315 (E), MDA-MB-435 (F),
MDA-MB-436 (G), or SUM
159PT (H) cells were photo-
graphed using an inverted
Zeiss microscope at 2003.
Bar, 10 mm. 
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of some breast cancer cell lines may be due to expression
of N-cadherin, rather than to lack of expression of E-cad-
herin. To test this hypothesis, we performed invasion as-
says on Matrigel-coated membranes and motility assays on
uncoated membranes. Fig. 3 presents data from represen-
tative cell lines. The N-cadherin–expressing cell lines,
SUM159 and MDA-MB-435, were substantially more in-
vasive and more motile than the E-cadherin–expressing
line (MCF-7), the E/P-cadherin–expressing cell lines (BT-20
and SUM149), and the P-cadherin–expressing line (SUM
1315). The cell line that did not express any cadherins,
SKBr3, was no more motile nor invasive than were the
E-cadherin–expressing cell lines BT-20, MCF-7, and SUM
149. Together, these data suggest that, in these cells, N-cad-
herin acts to promote motility and invasion, rather than
E-cadherin acting to suppress these activities.
Since the cell lines in this study were derived from sepa-
rate tumors and, thus, are likely to be descendents of dif-
ferent cell types, we sought to manipulate expression of
specific cadherins in representative cell lines to determine
if the invasive phenotype was due to N-cadherin or to
other cellular aspects. We chose two cell lines for these
studies: BT-20, which expresses E- and P-cadherin and has
a low rate of invasion, and MDA-MB-435, which ex-
presses N-cadherin and is highly invasive. When BT-20
cells were transfected with N-cadherin (BT-20N), they ex-
pressed levels of N-cadherin that were comparable to
MDA-MB-435; however, they did not undergo a morpho-
logical change (compare Fig. 2 B with Fig. 4 A), nor did
they downregulate the expression of E-cadherin to any
significant level. Fig. 4, B and C, show that E- and N-cad-
herin colocalized at cell–cell borders, suggesting that both
cadherins are active at the cell surface. When equal
amounts of protein from extracts of BT-20 and BT-20N
cells were resolved by SDS-PAGE and immunoblotted for
cadherin expression, it could be seen that the BT-20N cells
slightly downregulated E-cadherin, that the two cell lines
expressed equal levels of P-cadherin, and that the BT-20N
cells expressed levels of N-cadherin that were compara-
ble to the invasive N-cadherin–expressing cells depicted
in Fig. 1. In addition, 
 
b
 
-catenin coimmunoprecipitated
equally well with either E- or N-cadherin in these cells
(Fig. 4 E). BT-20 cells were unusual in that they expressed
high levels of both E- and N-cadherin and, thus, were an
ideal cell line in which to test the hypothesis that it is the
expression of N-cadherin, not the lack of E-cadherin, that
promotes cell motility and invasion in some breast cancer
cells. As predicted, motility and invasion rates for BT-20N
were five- to eightfold higher than the rates for nontrans-
fected BT-20 cells (Fig. 5). Although BT-20N cells were
not as motile as the N-cadherin–expressing MDA-MB-435
cells (Fig. 5 B), they were almost as invasive (Fig. 5 A).
 
E-Cadherin Does Not Suppress Motility in
N-Cadherin–expressing MDA-MB-435 Cells
 
Since the BT-20N cells expressed high levels of E-cad-
herin, and were highly motile and invasive, we had good
evidence that E-cadherin did not inhibit invasion in these
cells and, thus, does not act as an invasion suppressor in
all breast cancer cells. However, to further test this idea,
we transfected N-cadherin–expressing MDA-MB-435 cells
with E-cadherin (MDA-MB-435E) to see if E-cadherin
would decrease the invasive nature of these cells. In this
experiment, we sought to obtain clones that expressed
high levels of E-cadherin, but still retained a significant
level of N-cadherin. Fig. 6 D shows the levels of expression
of E- and N-cadherin in several clones. Clone 2 was chosen
for subsequent studies because it expressed the highest
level of E-cadherin and, in addition, showed a two- to
threefold reduction in N-cadherin expression, compared
Figure 3. N-cadherin expression correlates with increased inva-
siveness and motility in breast carcinoma cell lines. Cells were
plated on Matrigel-coated or noncoated membranes for invasion
assays or motility assays, respectively. The cells were incubated
for 24 h, and those that did not migrate through the pores in the
membrane were removed by scraping the membrane with a cot-
ton swab. The remaining cells were stained, and the number
transversing the membrane was determined by averaging ten
random fields of view at 1003. The data are expressed as the
number of cells/field of view and is the average of three indepen-
dent experiments. Error bars indicate SD of the average. 
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with the parental cells. Although these cells expressed
very high levels of E-cadherin, they did not display a typi-
cal epithelial morphology, and closely resembled the par-
ent cell line (compare Figs. 6 A with 2 F). Both E- and
N-cadherin were localized to regions of cell–cell contact
(Fig. 6, B and C). When the MDA-MB-435E cells
were  tested for motility and invasion, they were not signif-
icantly different from the parental MDA-MB-435 cells
(Fig. 5), even though b-catenin was associated with the
transfected E-cadherin, as well as the endogenous N-cad-
herin (Fig. 6 E).
BT-20N Cells Effectively Segregate from
HT1080 Fibroblasts
Hazan et al. (1997) suggested that N-cadherin–expressing
breast cancer cells invade the stroma because they associ-
ate with the N-cadherin–expressing stromal cells. In our
studies, we employed an in vitro invasion assay in which
the cells invade an extracellular matrix that does not in-
clude any stromal cells. Thus, we can make the important
statement that, in our studies, N-cadherin actively pro-
motes invasion and motility. In Hazan et al. (1997), the
investigators showed that N-cadherin–expressing breast
cancer cells coaggregated with N-cadherin–expressing fi-
broblast-like cells. Since it has been suggested that it is the
entire complement of cadherins expressed by a cell that
determines its ability to associate with other cells, and that
even cells expressing different levels of the same cadherin
can sort from one another (Steinberg and Takeichi, 1994),
we sought to determine if the BT-20N cells that express
N-, E-, and P-cadherin would segregate from an N-cad-
herin–expressing fibroblast cell line, HT1080. Equal num-
bers of BT-20 cells and HT1080 cells, or BT-20N cells and
HT1080 cells, were mixed together and allowed to settle
on glass coverslips. They were then prepared for immu-
nofluorescence analysis using antibodies against E- or
N-cadherin. In the immunofluorescence analysis of the
BT-20/HT1080 cocultures, E-cadherin stained only the
BT-20 cells and N-cadherin stained only the HT1080 cells.
Fig. 7, A and B, show that these two cell lines effectively
segregated from one another as expected. In the immu-
nofluorescence analysis of the BT-20N/HT1080 cocultures,
antibodies against E-cadherin stained only the BT-20N
cells, whereas antibodies against N-cadherin stained both
the BT-20N cells and the HT1080 cells. Fig. 7, C and D,
show that the BT-20N cells and the HT1080 cells effec-
tively segregated from one another, even though both cell
lines express N-cadherin. Thus, epithelial cells that ex-
press N-cadherin along with other cadherins have not
necessarily gained the ability to intermix with stromal
cells.
Cadherin-11 Promotes Motility in Breast
Epithelial Cells
In the course of our studies on breast tumor cell lines, we
characterized one atypical line (MDA-MB-231) that did
Figure 4. Expression of N-cad-
herin by BT-20 cells. BT-20
cells were transfected with
N-cadherin (BT-20N) and ex-
pression induced with dexa-
methasone. A, Phase-micros-
copy of living BT-20N cells.
Bar,  10  mm. B and C, Cells
were grown on glass cover-
slips and processed for coim-
munofluorescence localiza-
tion with antibodies against
E-cadherin (Jelly; B) and
N-cadherin (C). D, BT-20 and
BT-20N cells were extracted
with NP-40 and 20 mg protein
from each extract was re-
solved by SDS-PAGE, trans-
ferred to nitrocellulose, and
immunoblotted for E-cad-
herin (HECD1), N-cadherin,
or P-cadherin. E, Extracts of
BT-20N cells were immuno-
precipitated with antibodies
against N-cadherin or E-cad-
herin (HECD1). The immu-
noprecipitation reactions, as
well as cell extracts, were re-
solved by SDS-PAGE, trans-
ferred to nitrocellulose, and
immunoblotted for N-cad-
herin and b-catenin (lanes 1
and 2) or E-cadherin (HECD1)
and b-catenin (lanes 3 and 4).Nieman et al. N-Cadherin Promotes Cell Motility 637
not express E-, P-, or N-cadherin, but nonetheless was in-
vasive (Table I). Since MDA-MB-231 cells expressed sig-
nificant levels of b-catenin, a protein that is not stable in
cadherin-negative cells, we suspected that this cell line ex-
pressed another member of the cadherin family of pro-
teins, possibly one that is closely related to N-cadherin.
We therefore analyzed RNA from this line with degener-
ate PCR primers designed to amplify all cadherins and
found that it expressed cadherin-11 mRNA. Expression of
cadherin-11 protein was confirmed by immunoblotting
data with a cadherin-11–specific mAb, in agreement with
recent data (Pishvaian et al., 1999). Like N-cadherin, cad-
herin-11 is expressed by some mesenchymal cells (Simon-
neau et al., 1995). Interestingly, cadherin-11 is expressed
in some epithelial cells of the human placenta, and it has
been suggested that cadherin-11 plays a role in mediating
trophoblast–endometrium interactions as the cytotropho-
blasts invade the uterine wall (MacCalman et al., 1996).
Thus, one idea is that cadherin-11 could act in a manner
similar to N-cadherin in promoting cell motility and inva-
sion in breast cancer cells. To test this idea, we transfected
cadherin-11 into BT-20 cells (BT-20Cad-11 cells). Like the
BT-20N cells, BT-20Cad-11 cells retained the morphology
of their parent line, even though they expressed high levels
of cadherin-11 at cell–cell borders (Fig. 8, A–C). As pre-
dicted, cadherin-11–expressing BT-20 cells were more in-
vasive and motile than the parental BT-20 cells (Fig. 8, D
and E). Interestingly, the cadherin-11–expressing cells
were not as invasive or motile as the N-cadherin–express-
ing cells. For example, the MDA-MB-231 cells were not as
motile as the MDA-MB-435 cells (Figs. 5 and 8). More sig-
nificantly, the BT-20 cells transfected with cadherin-11 did
not become as motile as they did when transfected with
N-cadherin. This may be due to differences between the two
cadherins, or differences in expression levels of the trans-
fected cadherins. It is reasonable to speculate that the
level of expression of the inappropriate cadherin is rele-
vant since the cell line SUM1315 expresses a small amount
of cadherin-11, yet is not invasive.
N-Cadherin May Promote Cell Motility through a 
Fibroblast Growth Factor Receptor Signal
Transduction Pathway
The laboratories of Frank Walsh and Patrick Doherty
have shown that N-cadherin promotes neurite outgrowth
from cerebellar neurons (Williams et al., 1994a). In addi-
tion, they showed that N-cadherin–mediated neurite ex-
tension was dependent on FGF receptor signaling, but was
independent of ligand (Williams et al., 1994b). Walsh and
Doherty thus proposed a model whereby the FGF recep-
tor was induced to dimerize in the absence of FGF via in-
teraction with N-cadherin (Doherty and Walsh, 1996).
Dimerization of the FGF receptor results in receptor cross
phosphorylation that initiates a number of signal trans-
duction pathways. The pathway relevant to N-cadherin–
dependent neurite outgrowth involves the generation of
arachidonic acid from diacylglycerol, by the action of di-
acylglycerol lipase. The Walsh and Doherty laboratories
showed that the diacylglycerol lipase inhibitor, RHC
80267, prevented neurite extension on N-cadherin–trans-
fected 3T3 cells, thus implicating this type of FGF recep-
tor signaling in N-cadherin–dependent neurite extension
(Meiri et al., 1998). We hypothesized that the N-cadherin–
mediated cell motility we observed in epithelial cells may
also be acting through FGF receptor signaling. To test this
hypothesis, we treated MDA-MB-435 cells, BT-20 cells,
Figure 5. Exogenous expression of N-cadherin by BT-20 cells
(BT-20N) increases their invasiveness, whereas exogenous ex-
pression of E-cadherin by MDA-MB-435 cells (MDA-MB-435E)
does not effect their behavior. Cells were plated on Matrigel-
coated or noncoated membranes for invasion assays or motility
assays, respectively. The cells were incubated for 24 h, and those
that did not migrate through the pores in the membrane were re-
moved by scraping the membrane with a cotton swab. The re-
maining cells were stained, and the number transversing the
membrane was determined by averaging ten random fields of
view at 1003. The data are expressed as the number of cells/field
of view and is the average of three independent experiments. Er-
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and BT-20N cells with varying levels of RHC80267 to de-
termine if it would influence the motility of these cells in
the transwell assay. RHC80267 inhibited cell motility in
both N-cadherin–expressing cell lines in a dose-dependent
manner (Fig. 9 A). Importantly, this inhibitor had no ef-
fect on the motility of the N-cadherin–negative BT-20
cells. Although these data are consistent with the hypothe-
sis that N-cadherin dependent cell motility is mediated
through FGF receptor signaling in a manner similar to
N-cadherin–dependent neurite outgrowth, additional ex-
periments must be done to further support this notion.
Thus, we are continuing to investigate the mechanism
whereby N-cadherin mediates motility in epithelial cells.
To determine if cadherin-11 and N-cadherin promote cell
motility through a similar pathway, we treated MDA-MB-
231 and BT-20cad11 cells with RHC80267, and compared
Figure 6. Expression of E-cad-
herin by MDA-MB-435 cells.
MDA-MB-435 cells were
transfected with E-cadherin
(MDA-MB-435E) and ex-
pression was induced with
dexamethasone. A, Phase-
microscopy of MDA-MB-
435E cells. Bar, 10 mm. B and
C, Cells were grown on glass
coverslips and processed for
coimmunofluorescence lo-
calization with antibodies
against E- (Jelly; B) and
N-cadherin (C). D, MDA-
MB-435 and several clones of
MDA-MB-435E cells were
extracted with NP-40 and 20
mg protein from each extract
was resolved by SDS-PAGE,
transferred to nitrocellulose,
and immunoblotted for E-
(HECD1) and N-cadherin.
Clone 2 (cl2) expressed the
highest level of E-cadherin
and was chosen for subsequent studies. E, Extracts of MDA-MB-435 and MDA-MB-435E cells were immunoprecipitated with antibod-
ies against N- or E-cadherin (HECD1). The immunoprecipitation reactions, along with cell extracts, were resolved by SDS-PAGE,
transferred to nitrocellulose, and immunoblotted for N-cadherin and b-catenin (lanes 1 and 2), or E-cadherin (HECD1) and b-catenin
(lanes 3 and 4).
Figure 7. BT-20N cells do
not mix with HT1080 cells.
5 3 104 BT-20 or BT-20N
cells were mixed with an
equal number of HT1080
cells, allowed to settle on
coverslips, and processed for
immunofluorescence with an
mAb against N- (13A9) or
E-cadherin (Jelly). A and B
are a mix of BT-20 and
HT1080 cells stained for
E- and N-cadherin, respec-
tively. The encircled cells are
a group of E-cadherin–nega-
tive, N-cadherin–positive
HT1080 cells. C and D are a
mix of BT-20N and HT1080
cells stained for E- and N-cad-
herin, respectively. The en-
circled cells are a group of
E-cadherin–negative, N-cad-
herin–positive HT1080 cells. Nieman et al. N-Cadherin Promotes Cell Motility 639
motility rates between treated and nontreated cells (Fig. 9
B). The diacylglycerol lipase inhibitor decreased the motil-
ity of cadherin-11–expressing cells in a dose-dependent
manner. Cadherin-11–expressing cells are less motile than
MDA-MB-435, and the inhibitor is less effective in de-
creasing the motility of the cadherin-11 expressing cells,
suggesting there may be some differences in the respective
signal transduction pathways, possibly in growth factor re-
ceptor levels or isoforms.
Discussion
Previously, our laboratory showed that expression of dif-
ferent cadherin family members by squamous epithelial
cells markedly effected morphology (Islam et al., 1996),
i.e., when oral squamous epithelial cells expressed N-cad-
herin, they converted to a fibroblastic phenotype concur-
rent with decreased cell–cell adhesion. Thus, when we
turned our attention to breast cancer cells for the present
study, we were interested not only in the expression of var-
ious cadherins by these cells, but also in whether these
cadherins influenced the morphology of the cells. We were
not surprised to find that breast cancer cells endogenously
expressing N-cadherin displayed a fibroblastic phenotype
with tenuous cell–cell contacts, whereas breast cancer cells
endogenously expressing E-cadherin displayed a typical
epithelial morphology. We were, however, surprised to
find that transfection of N-cadherin into the E-cadherin–
expressing BT-20 breast cancer cell line had no effect on
morphology, even though it had a dramatic effect on cell
behavior. Equally surprising was the fact that forced ex-
pression of E-cadherin had no effect on the morphology
of the fibroblastic N-cadherin–expressing MDA-MB-435
cells. Thus, the breast cancer cell lines examined in this
study behaved very differently from the oral squamous ep-
ithelial lines that we characterized previously. Interest-
ingly, the oral squamous epithelial cells downregulated
E-cadherin when they were forced to express N-cadherin,
suggesting an inverse relationship between these cad-
herins. In contrast, the breast cancer cells continued to ex-
press their endogenous cadherin(s) when transfected with
a different cadherin. The continued expression of endoge-
nous cadherin may account for the lack of morphological
change in the transfectants. Thus, the breast cancer cells
differ from the oral squamous epithelial cells in two very
important ways: first, the oral squamous epithelial cells
appear to coregulate cadherins in an inverse manner,
whereas these cadherins are independently regulated in
breast cancer cells; and second, expression of E-cadherin
by the oral squamous epithelial cells is sufficient for epi-
thelial morphology, whereas epithelial morphology in the
breast cancer cells appears to depend on other factors, in
addition to E-cadherin.
In the present study, we have demonstrated that N-cad-
herin (or cadherin-11) expression in human breast carci-
noma cells promotes an invasive phenotype. By transfect-
ing the BT-20 cells with these nonepithelial cadherins, we
have provided evidence for a direct role of these cadherins
in cell motility and invasion. Previous studies have corre-
lated the expression of N-cadherin or cadherin-11 with in-
vasion in breast cancer cells. However, in this study, we
took the important next step and used transfection studies
to show that a cell line that has a low invasion rate could
be converted to a highly invasive cell by expression of
N-cadherin or cadherin-11. The BT-20 breast cancer cell
line provided an important tool for these studies since they
did not downregulate E-cadherin when forced to express
N-cadherin. Thus, we can conclude that, even in cells ex-
pressing high levels of E-cadherin, N-cadherin (or cad-
herin-11) can promote motility, suggesting that, in this re-
gard, both N-cadherin and cadherin-11 are dominant over
E-cadherin. A study by Sommers et al. (1994) supports
this idea. These authors showed that transfection of E-cad-
herin into the E-cadherin–negative breast cancer cell lines,
BT549 and HS578, did not decrease the invasive capacity
of these cells. These authors suggested that the transfected
E-cadherin was not functional; however, these authors
were unaware of the fact that the BT549 and HS578 cell
lines express N-cadherin.
A previous study using MDA-MB-435 cells showed that
transfection of E-cadherin into these cells reduced their
capacity to form tumors when injected into the foot pads
of nude mice (Meiners et al., 1998). In contrast to our
study, these authors showed that E-cadherin–transfected
clones of MDA-MB-435 cells underwent a morphological
Figure 8. Exogenous expression of cadherin-11 by BT-20 cells
(BT-20cad11) increases their invasiveness. BT-20 cells were
transfected with cadherin-11 (BT-20cad11) and expression in-
duced with dexamethasone. A, Phase-microscopy of living BT-
20cad11 cells. Bars, 10 mm. B and C, Cells were grown on glass
coverslips and processed for coimmunofluorescence localization
with antibodies against E-cadherin (Jelly; B) and cadherin-11
(C). D and E, Cells were plated on Matrigel-coated or noncoated
membranes for invasion assays or motility assays, respectively.
The cells were incubated for 24 h, and those that did not migrate
through the pores in the membrane were removed by scraping
the membrane with a cotton swab. The remaining cells were
stained, and the number transversing the membrane was deter-
mined by averaging ten random fields of view at 100 3. The data
are expressed as the number of cells/field of view and is the aver-
age of three independent experiments. Error bars indicate SD of
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change upon E-cadherin expression. In addition, they
showed that E-cadherin–transfected clones were less tu-
morigenic in their assay than the parental cells. One differ-
ence in the study of Meiners et al. (1998) and ours is that
they did not assay for N-cadherin expression in their
E-cadherin–positive clones of MDA-MB-435 transfec-
tants. Our study clearly demonstrates that N-cadherin in-
fluences the behavior of the cells, and that cells retaining
N-cadherin do not undergo a morphological or behavioral
change upon expression of E-cadherin. Thus, one possible
explanation for the difference between these two studies is
that the cells in the Meiners’ study did not express N-cad-
herin. The point of our study was to determine if N-cad-
herin was capable of influencing the behavior of epithelial
cells, even if they expressed E-cadherin, thus, we were par-
ticularly careful to select cell lines that retained N-cad-
herin expression after transfection with E-cadherin (Fig. 6).
One puzzling aspect of cell lines derived from metastatic
tumors is that they often express E-cadherin and appear to
be relatively normal epithelial cells. A possibility sug-
gested by the present study is that such cells may have up-
regulated the expression of N-cadherin during the process
of metastasis. Our results suggest that expression of N-cad-
herin would confer on these cells the capacity to invade,
even though they continued to express E-cadherin. In this
regard, expression of an inappropriate cadherin like N-cad-
herin (or other related cadherins) may be a better gauge of
the clinical state of a tumor than is decreased expression of
E-cadherin.
Some of the E-cadherin–negative breast cancer cells
expressed endogenous P-cadherin. These cells had a fi-
broblastic morphology similar to that of the N-cadherin–
expressing cells; however, they were not highly invasive,
suggesting that P-cadherin confers upon breast cancer
cells characteristics different from those conferred by ei-
ther E- or N-cadherin. P-cadherin is expressed in the myo-
Figure 9. The diacylglycerol
lipase inhibitor RHC80267
decreases motility of N-cad-
herin– and cadherin-11–
expressing cells. Cells were
plated on noncoated mem-
branes for motility assays.
The cells were incubated for
24 h in the presence of
RHC80267 at varying con-
centrations, and those that
did not migrate through the
pores in the membrane were
removed by scraping the
membrane with a cotton
swab. The remaining cells
were stained, and the number
transversing the membrane
was determined by averaging
ten random fields of view at
1003. The data are expressed
as the number of cells/field of
view and is the average of
three (A) or two (B) in-
dependent experiments. Er-
ror bars indicate SD of the
average.Nieman et al. N-Cadherin Promotes Cell Motility 641
epithelial cells surrounding the lumenal epithelial cells of
the mammary gland. Radice et al. (1997) recently showed
that P-cadherin deficient mice develop age-dependent hy-
perplasia and dysplasia of the mammary epithelium, and
suggested that P-cadherin may play a role in maintaining
the normal phenotype of breast epithelial cells. One possi-
bility is that the P-cadherin–expressing tumor cells were
derived from the myoepithelium, rather than from the true
epithelium.
E-cadherin has been termed an invasion suppressor be-
cause transfection of this protein into some E-cadherin–
negative invasive carcinoma cells resulted in decreased in-
vasive capacity. Our prediction is that at least some of
these cell lines cells expressed a cadherin, like N-cadherin
or cadherin-11, and overexpression of E-cadherin resulted
in downregulation of the endogenous cadherin, as we saw
with the oral squamous epithelial cells. Thus, we hypothe-
size that the invasion suppressor role of E-cadherin arises
in part from its ability to decrease the level of N-cadherin
in certain, but not all, tumors. In the present study, cell
lines that did not express any classical cadherins, as evi-
denced by lack of b-catenin protein, as well as lack of de-
tectable cadherin, had low invasion rates. Our hypothesis,
that loss of E-cadherin alone does not necessarily increase
invasive capacity in breast carcinoma cells, is supported by
the observation that function-blocking antibodies against
E-cadherin did not confer a highly motile, invasive pheno-
type on MCF-7 cells, a breast cancer cell line that is E-cad-
herin–positive and N-cadherin–negative (Sommers et al.,
1991). The current study suggests that, in some carcinoma
cells, expression of N-cadherin, or a similar cadherin such
as cadherin-11, may actually be necessary for increased
motility and invasion. A recent clinical study suggested
that inactivation of E-cadherin is an early event in the pro-
gression of lobular breast carcinomas (Vos et al., 1997).
We might suggest that a subsequent event would be acti-
vation of the expression of an inappropriate cadherin, such
as N-cadherin or cadherin-11.
Understanding the mechanism by which N-cadherin
promotes motility in epithelial cells is important if we are
to develop treatments that will decrease the invasiveness
of tumor cells. A number of studies have shown that epi-
thelial cells can be induced to scatter in response to growth
factors, such as hepatocyte growth factor and members of
the FGF, EGF, and TGF families (Blay and Brown, 1985;
Vallés et al., 1990; Behrens et al., 1991; Geimer and Bade,
1991; Gherardi and Stoker, 1991; Rosen et al., 1991; Miet-
tinen et al., 1994; Savagner et al., 1994, 1997). Walsh,
Doherty, and coworkers have established, through exten-
sive studies on FGF receptor and cell adhesion molecules,
that N-cadherin and the FGF receptor cooperate to induce
neurite outgrowth in cerebellar neurons (reviewed in
Doherty and Walsh, 1996; Walsh and Doherty, 1997).
These authors have proposed a scheme for activation of
the kinase activity of the FGF receptor through cis interac-
tions with N-cadherin, via an HAV domain in the FGF re-
ceptor and an HAV interaction domain in the fourth ex-
tracellular domain of N-cadherin (Doherty and Walsh,
1996). In addition, it has been proposed that the cadherins
form lateral dimers in the plane of the membrane (Shapiro
et al., 1995; Takeda et al., 1999), which could result in
dimerization of the FGF receptor, and subsequent activa-
tion of the signal transduction pathway. We based the
studies presented herein on the model presented by Walsh
and Doherty, and proposed that interaction of N-cadherin
with the FGF receptor in N-cadherin–expressing epithelial
cells may result in increased motility, similar to that seen
by treating epithelial cells with growth factors. To test this
hypothesis, we interfered with the N-cadherin–dependent
FGF receptor signal transduction pathway proposed by
Walsh and Doherty by inhibiting a downstream enzyme,
diacylglycerol lipase. We showed that inhibiting diacyl-
glycerol lipase decreased motility of N-cadherin–expressing
cells in a dose-dependent manner while having no effect
on the motility of N-cadherin–negative cells. Thus, our
data strongly support the notion that N-cadherin promotes
motility in breast cancer cells by activating growth factor
receptor signal transduction pathways. Continued efforts
in our laboratory are aimed at further defining the signal
transduction pathway(s) that mediate cadherin-dependent
motility in epithelial cells.
At first glance, it might seem unlikely that expression of
an additional cell adhesion molecule would confer a mo-
tile and invasive phenotype upon an epithelial cell. How-
ever, motile cells, such as fibroblasts and myoblasts, ex-
press N-cadherin (Knudsen et al., 1995; Huttenlocher et
al., 1998) and a switch from E- to N-cadherin occurs in the
chick embryo when epiblast cells ingress through the
primitive streak to form the mesoderm (Edelman et al.,
1983; Hatta and Takeichi, 1986). Another interesting cad-
herin switch occurs during establishment of the human
placenta, where fetal cytotrophoblast cells invade the vas-
culature of the uterus. During this invasive process, the
cytotrophoblast cells downregulate the expression of
E-cadherin and upregulate vascular/endothelial (VE)
cadherin (Zhou et al., 1997). Thus, it is feasible to suggest
that increased expression of a nonepithelial cell cadherin,
such as N-cadherin, could increase the invasive potential
of tumor cells. Ongoing studies in our laboratory are de-
signed to determine how N-cadherin differs from E-cad-
herin in its ability to induce cell motility. We hypothesize
that E-cadherin does not have the ability to interact with
the relevant growth factor receptors, and we are prepar-
ing chimeric molecules between E- and N-cadherin to test
this hypothesis.
An important message from the present studies is that
cadherins may not function identically in different cell
types. The fact that cadherins may act differently in differ-
ent cell types is particularly evident when comparing the
current study with earlier studies showing that mouse L
cells or S180 fibroblasts attained an epithelial morphology
when transfected with either E- or N-cadherin (Nagafuchi
et al., 1987; Hatta et al., 1988; Matsuzaki et al., 1990). It
will be important in future studies to consider the cellular
makeup, as well as the complement of cadherin family
members, when interpreting data on cellular morphology
and behavior.
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